As per SNS Insider’s research, the flow cytometry market robust growth is underpinned by a confluence of factors, including advancements in research, the prevalence of chronic diseases, pharmaceutical research activities, the demand for point-of-care testing, and expanding applications in clinical diagnostics.

The flow cytometry market, as reported by SNS Insider, was valued at USD 4,561.79 million in 2022. It is expected to experience a compound annual growth rate (CAGR) of 7.19% from 2023 to 2030, reaching an estimated value of USD 7,950 million by the end of 2030.

Market Report Scope

Flow cytometry is a sophisticated technique used in biology and medicine to analyze and characterize cells and particles in a fluid suspension. This technology allows scientists to examine and quantify various properties of cells, such as their size, shape, complexity, and the presence or absence of specific molecules on their surface. Flow cytometry is widely used in research, clinical diagnostics, and drug development due to its ability to provide detailed information about individual cells in a high-throughput manner. One of the significant advantages of flow cytometry is its ability to analyze thousands of cells per second, providing statistically relevant data and enabling the identification of rare cell populations within a sample.

Get Free PDF Sample Report:

Market Analysis

The continuous advancements in biomedical research necessitate sophisticated tools for cellular analysis. Flow cytometry, with its ability to analyze multiple parameters simultaneously, has become an indispensable tool in various research areas such as cancer biology, immunology, and stem cell research. Researchers worldwide rely on flow cytometry to explore complex biological phenomena, thereby driving the flow cytometry market’s growth. The global increase in chronic diseases like cancer, HIV/AIDS, and autoimmune disorders has intensified the demand for accurate diagnostic techniques. Flow cytometry plays a pivotal role in diagnosing and monitoring these conditions by enabling the analysis of specific biomarkers and immune cell populations. As the prevalence of these diseases continues to rise, the market is propelled further. Ongoing technological innovations have significantly enhanced the capabilities of flow cytometers. The development of high-throughput flow cytometry platforms, coupled with advanced software solutions, has improved the speed and accuracy of data analysis. Additionally, the integration of artificial intelligence and machine learning algorithms into flow cytometry data analysis has opened new avenues for research, attracting both academia and industry stakeholders.

Major Players Listed in the Report are as Follows:

Beckman coulter, Inc., Danaher Corporation, Becton, Dickinson and Company, DiaSorin S.p.A., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, Stratedigm, Inc., Apogee Flow Systems Ltd., Sony Biotechnology, Inc., and Thermo Fisher Scientific, Inc. and others.

Flow Cytometry Market Segmentation as Follows:

By Technology

  • Cell-Based
  • Bead-Based

By Product and Services

  • Regards and consumables
  • Instruments
    • Cell Analyzers
      • High-range
      • Mid-range
      • Low-range
    • Cell Sorters
      • High-range
      • Mid-range
      • Low-range
    • Services
    • Software
    • Accessories 

 By Application

  • Research Application
    • Pharmaceuticals and Biotechnology
      • Drug Discovery
      • Stem Cell research
      • In Vitro Toxicity Testing
    • Immunology
    • Cell sorting
    • Apoptosis
    • Cell Cycle analysis
    • Cell viability
    • Cell counting
    • Other research application
  • Clinical Application
    • Cancer Diagnostic
    • Hematology
    • Autoimmune
    • Organ Transplantation
    • Other Clinical Application
  • Industrial Application

By End-User

  • Academic & Research institutes
  • Hospitals & clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

Impact of Recession

While the ongoing recession has undeniably posed challenges for the flow cytometry market, it has also spurred innovation and adaptation. Market players are redefining strategies, focusing on cost-effective solutions, and investing in research to meet the evolving demands of researchers in a financially constrained environment. By embracing change and prioritizing innovation, the market has the potential not only to weather the storm of the recession but also to emerge stronger and more resilient in the face of future challenges.

Impact of Russia-Ukraine War

The Russia-Ukraine war has cast a shadow over the global flow cytometry market, affecting various aspects such as supply chains, research collaborations, market volatility, and regional demand. As the conflict continues, industry stakeholders need to adapt to these challenges, exploring new avenues for collaboration, diversifying supply sources, and finding innovative solutions to sustain the growth and development of the market amidst these turbulent times.

Need Customized Report as per Your Business Requirement Ask Here:

Key Regional Development

North America stands at the forefront of the global flow cytometry market, primarily due to the presence of leading biotech and pharmaceutical companies, along with substantial investments in research and development. The region’s market dominance can be attributed to the continuous development of cutting-edge technologies and the increasing adoption of flow cytometry in clinical diagnostics. Europe boasts a robust market, supported by a strong emphasis on research and development activities. Leading European countries, such as Germany, France, and the United Kingdom, are witnessing a surge in demand for flow cytometry solutions in both academic research and clinical applications. The Asia-Pacific region is witnessing a remarkable expansion in the market, driven by increasing investments in healthcare infrastructure and research facilities. Countries like China, Japan, and India are experiencing a growing demand for flow cytometry techniques in cancer research, immunology, and stem cell studies.

Key Takeaway from Flow Cytometry Market Study

In recent years, the cell-based segment in the field of flow cytometry has undergone a transformative evolution, redefining the landscape of medical research and diagnostics. With advancements in technology and an enhanced understanding of cell biology, researchers and clinicians are leveraging cell-based flow cytometry to unravel complex biological processes and improve patient care.

The clinical application segment of flow cytometry has emerged as a cornerstone in modern healthcare, offering innovative solutions for disease diagnosis, monitoring, and personalized treatment strategies. Flow cytometry in clinical applications enables the early detection of diseases, including cancers, immunodeficiencies, and hematological disorders.

Recent Developments Related to Flow Cytometry Market

FlowMetric, a prominent entity under the umbrella of KCAS (Kentucky Chromatography and Analytical Services) Company, has recently made waves in the scientific community with its groundbreaking collaboration announcement. The company proudly unveiled its partnership with Cytek™ Biosciences, a leading name in cutting-edge technology in the field of cytometry.

In a groundbreaking move that promises to reshape the landscape of clinical diagnostics, BD, a global leader in medical technology, has unveiled its latest innovation: a state-of-the-art robotic system designed to automate clinical flow cytometry processes. This revolutionary advancement not only signifies a leap forward in medical technology but also holds the potential to significantly enhance the efficiency and accuracy of diagnostic procedures.

For more information or to purchase the Flow Cytometry Market report:

Table of Content

Chapter 1 Introduction 

Chapter 2 Research Methodology

Chapter 3 Flow Cytometry Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Flow Cytometry Market Segmentation, By Technology

Chapter 9 Flow Cytometry Market Segmentation, By Product and Services

Chapter 10 Flow Cytometry Market Segmentation, By Application

Chapter 11 Flow Cytometry Market Segmentation, By End-Use

Chapter 12 Regional Analysis

Chapter 13 Company profile

Chapter 14 Competitive Landscape

Chapter 15 Use Case and Best Practices

Chapter 16 Conclusion

Other Reports

Regenerative Medicine Market

Medical Imaging Market

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Tags: , , , , , , , , , , ,

See Campaign:

Contact Information:

Contact Us: Akash Anand – Head of Business Development & Strategy, [email protected], Phone: +1-415-230-0044 (US) | +91-7798602273 (IND), Website:

IPS, iCN Internal Distribution, Extended Distribution, Go Media, BNN, Research Newswire, English